• 1
    Marshall R.I., Bartold P.M. Medication induced gingival overgrowth. Oral Dis. (1998) 4 130151.
  • 2
    Nakib N., Ashrafi S.S. Drug-induced gingival overgrowth. Dis. Mon. (2011) 57 225230.
  • 3
    Corrȇa J.D., Queiroz-Junior C.M., Costa J.E., Teixeira A.L., Silva T.A. Phenytoin-induced gingival overgrowth: a review of the molecular, immune, and inflammatory features. ISRN Dent. (2011) 2011 497850, pp. 8. doi: doi: 10.5402/2011/497850.
  • 4
    Kato T., Okahashi N., Ohno T., Inaba H., Kawai S., Amano A. Effect of phenytoin on collagen accumulation by human gingival fibroblasts exposed to TNF-alpha in vitro. Oral Dis. (2006) 12 156162.
  • 5
    Hassell T.M., Hefti A.F. Drug-induced gingival overgrowth: old problem, new problem. Crit. Rev. Oral Biol. Med. (1991) 2 103137.
  • 6
    Hallmon W.W., Rossmann J.A. The role of drugs in the pathogenesis of gingival overgrowth. A collective review of current concepts. Periodontol 2000 (1999) 21 176196.
  • 7
    Shafer W.G. Effect of dilantin sodium analogues on cell proliferation in tissue culture. Proc. Soc. Exp. Biol. Med. (1961) 106 205207.
  • 8
    Vernillo A.T., Schwartz N.B. The effects of phenytoin (5,5-diphenylhydantoin) on human gingival fibroblasts in culture. J. Periodontal Res. (1987) 22 307312.
  • 9
    Vijayasingham S.M., Dykes P.J., Marks R. Phenytoin has little effect on in-vitro models of wound healing. Br. J. Dermatol. (1991) 125 136139.
  • 10
    Alikhani M., Alikhani Z., Graves D.T. Apoptotic effects of LPS on fibroblasts are indirectly mediated through TNFR1. J. Dent. Res. (2004) 83 671676.
  • 11
    Kantarci A., Augustin P., Firatli E. et al. Apoptosis in gingival overgrowth tissues. J. Dent. Res. (2007) 86 888892.
  • 12
    van Harn T., Foijer F., van Vugt M. et al. Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling. Genes Dev. (2010) 24 13771388.
  • 13
    Foijer F., te Riele H. Check, double check: the G2 barrier to cancer. Cell Cycle (2006) 5 831836.
  • 14
    Jang S.I., Lee E.J., Hart P.S., Ramaswami M., Pallos D., Hart T.C. Germ line gain of function with SOS1 mutation in hereditary gingival fibromatosis. J. Biol. Chem. (2007) 282 2024520255.
  • 15
    Lee E.J., Jang S.I., Pallos D., Kather J., Hart T.C. Characterization of fibroblasts with Son of Sevenless-1 mutation. J. Dent. Res. (2006) 85 10501055.
  • 16
    Sano M., Ohuchi N., Inoue T. et al. Proliferative response to phenytoin and nifedipine in gingival fibroblasts cultured from humans with gingival fibromatosis. Fundam. Clin. Pharmacol. (2004) 18 465470.
  • 17
    Takeuchi R., Matsumoto H., Okada H. et al. Differences of cell growth and cell cycle regulators induced by basic fibroblast growth factor between nifedipine responders and non-responders. J. Pharmacol. Sci. (2007) 103 168174.
  • 18
    Takeuchi R., Matsumoto H., Akimoto Y., Fujii A. Reduction in lipopolysaccharide-induced apoptosis of fibroblasts obtained from a patient with gingival overgrowth during nifedipine-treatment. Arch. Oral Biol. (2011) 56 10731080.
  • 19
    Kato T., Okahashi N., Kawai S. et al. Impaired degradation of matrix collagen in human gingival fibroblasts by the antiepileptic drug phenytoin. J. Periodontol. (2005) 76 941950.
  • 20
    Yamada H., Nishimura F., Naruishi K. et al. Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts. J. Periodontol. (2000) 71 955960.
  • 21
    Bosi G., Evangelisti R., Valeno V. et al. Diphenylhydantoin affects glycosaminoglycans and collagen production by human fibroblasts from cleft palate patients. J. Dent. Res. (1998) 77 16131621.
  • 22
    Yu M.J., Yang P.S., Ge S.H. Biological effects of phenytoin on cultured human periodontal ligament fibroblasts in vitro. Hua Xi Kou Qiang Yi Xue Za Zhi (2008) 26 215218.
  • 23
    McLaughlin W.S., Ball D.E., Seymour R.A., Kamali F., White K. The pharmacokinetics of phenytoin in gingival crevicular fluid and plasma in relation to gingival overgrowth. J. Clin. Periodontol. (1995) 22 942945.
  • 24
    Ekholm S.V., Reed S.I. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr. Opin. Cell Biol. (2000) 12 676684.
  • 25
    Nevins J.R., Leone G., DeGregori J., Jakoi L. Role of the Rb/E2F pathway in cell growth control. J. Cell. Physiol. (1997) 173 233236.
  • 26
    Baus F., Gire V., Fisher D., Piette J., Dulić V. Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts. EMBO J. (2003) 22 39924002.
  • 27
    Harper J.W., Elledge S.J., Keyomarsi K. et al. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell (1995) 6 387400.
  • 28
    Castro L.A., Elias L.S., Oton-Leite A.F. et al. Long-term effects of nifedipine on human gingival epithelium: a histopathological and immunohistochemical study. J. Oral Sci. (2010) 52 5562.
  • 29
    Bulut S., Ozdemir B.H., Alaaddinoĝlu E.E., Oduncuoĝlu F.B., Bulut O.E., Demirhan B. Effect of cyclosporin A on apoptosis and expression of p53 and bcl-2 proteins in the gingiva of renal transplant patients. J. Periodontol. (2005) 76 691695.
  • 30
    Buduneli E., Genel F., Atilla G., Kütükçüler N. Evaluation of p53, bcl-2, and interleukin-15 levels in gingival crevicular fluid of cyclosporin A-treated patients. J. Periodontol. (2003) 74 506511.
  • 31
    Saito K., Mori S., Tanda N., Sakamoto S. Expression of p53 protein and Ki-67 antigen in gingival hyperplasia induced by nifedipine and phenytoin. J. Periodontol. (1999) 70 581586.
  • 32
    Jung J.Y., Jeong Y.J., Jeong T.S., Chung H.J., Kim W.J. Inhibition of apoptotic signals in overgrowth of human gingival fibroblasts by cyclosporin A treatment. Arch. Oral Biol. (2008) 53 10421049.